Arrow
Arrow
Liv Doctors
Arrow
Prof. MD. Mehmet Mustafa Can
Prof. MD. Mehmet Mustafa Can
Prof. MD.

Mehmet Mustafa Can

Cardiology
Areas of Interests
    • All Procedures in Interventional Cardiology (Coronation Interventions),
    • Peripheral Endovascular Procedures (EVAR, TEVAR,
    • Interventional Treatment of Peripheral Vascular Diseases,
    • Treatment of Venous Thrombosis and Diseases,
    • Neurovascular interventions (Carotid Stenting, Interventional Treatment of Acute Stroke)
    • Electrophysiology (Treatment of Heart Rhythm Diseases, Ablation and Battery Applications)
    • Interventional Treatments for Structural and Heart Valve Diseases (Transcatheter Aortic Valve Implantation (TAVI), Mitral Balloon Valvuloplasty, Atrial Septal Defect Closure, Ventricular Septal Defect Closure, Patent Ductus Arteriosus Closure, Aortic Coartation Treatment, Left Atrial Appendage Closure)
Resume
Publications
Memberships
Awards
Courses Attended
Education
  • Malatya Science High School
  • Cerrahpasa English Faculty of Medicine
Specialty Training:
  • Kartal Kosuyolu High Specialization Training and Research Hospital
Institutions he worked for:
  • Cardiology Clinic Chief (Health Sciences University Haseki Training and Research Hospital Cardiology Clinic (2014-2023)
  • Cleveland Clinic Cardiology Department, USA 2010
Articles published in international refereed journals:
  • A1. Kirma C, Izgi A, Yakut C, Guler M, Can M, Zemheri E. Primary left ventricular angiomatosis: first description of a rare vascular tumor in the left heart. Int Heart J. 2006;47(3):469-74.
  • A2. Miller M, DiNicolantonio JJ, Can M, Grice R, Damoulakis A, Serebruany VL. The  effects of ezetimibe/simvastatin versus simvastatin monotherapy on platelet and inflammatory biomarkers in patients with metabolic syndrome. Cardiology. 2013;125(2):74-7. doi: 10.1159/000347134.
  • A3. Serebruany VL, Pokov AN, Aradi D, Can M, DiNicolantonio J, Kipshidze N, AtarD. Effect of aliskiren and valsartan combination versus aliskiren monotherapy on hemostatic biomarkers in hypertensive diabetics: Aliskiren and Valsartan Impactin Diabetics pilot trial. Am J Ther. 2014;21(6):482-90. doi:10.1097/MJT
  • A4. Can MM, Tanboga IH, Turkyilmaz E, Akgun T, Kaymaz C. Takotsubo cardiomyopathy  in a patient with emotional stress. Am J Psychiatry. 2008;165(8):1052-3. doi: 10.1176/appi.ajp.2008.08010127.
  • A5. Sengul C, Cevik C, Ozveren O, Sunbul A, Oduncu V, Akgun T, Can MM, Semiz E, Dindar I. Acute alcohol consumption is associated with increased interatrial electromechanical delay in healthy men. Cardiol J. 2011;18(6):682-6.
  • A6. Can MM, Tanboga H, Karabay CY, Güler A, Akgun T, Turkyilmaz E, Ozveren O, Mutlu B. The treatment of acute myocardial infarction due to the occlusion of the left main coronary disease. Cardiol J. 2011;18(1):77-82.
  • A7. Karabay CY, Biteker M, Zehir R, Bezgin T, Tanboga H, Can MM, Güler A, Duran NE, Ozkan M. Multiple spontaneous coronary artery dissection associated with Trousseau's syndrome. Cardiol J. 2010;17(6):625-7. 
  • A8. Biteker M, Dayan A, Can MM, İlhan E, Biteker FS, Tekkeşin A, Duman D. Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery. Cardiovasc Diabetol. 2011;10:63. doi: 10.1186/1475-2840-10-63.
  • A9. Sahin I, Ozkaynak B, Sar M, Biter HI, Mert B, Okuyan E, Kayalar N, Can MM, Güngör B, Erentug V, Dinckal MH. Paricalcitol counteracts the increased contrast induced nephropathy caused by renin-angiotensin-aldosterone system blockade therapy in a rat model. Eur Rev Med Pharmacol Sci. 2014;18(19):2895-902.
  • A10. Can MM, Kaymaz C, Tanboga IH, Tokgoz HC, Canpolat N, Turkyilmaz E, Sonmez K, Ozdemir N. Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension. Clin Nucl Med. 2011;36(9):743-8. doi: 10.1097/RLU.0b013e3182177389.
  • A11. Turan B, Erkol A, Yılmaz F, Can MM, Erden İ. Incidence and predictors of radial artery injury following transradial procedures: Yet another benefit of renin-angiotensin system blockade? Cardiol J. 2016;23(1):64-70. doi: 10.5603/CJ.a2015.0057.
  • A12. Bilen E, Kurt M, Tanboga IH, Kaya A, Isik T, Ekinci M, Can MM, Karakas MF, Oduncu V, Bayram E, Aksakal E, Sevimli S. Severity of mitral stenosis and left ventricular mechanics: a speckle tracking study. Cardiology. 2011;119(2):108-15.  doi: 10.1159/000330404.
  • A13. Sengul C, Cevik C, Ozveren O, Duman D, Eroglu E, Oduncu V, Tanboga HI, Can MM, Akgun T, Dindar I. Epicardial fat thickness is associated with non-dipper blood pressure pattern in patients with essential hypertension. Clin Exp Hypertens. 2012;34(3):165-70. doi: 10.3109/10641963.2011.577488. 
  • A14. Sengul C, Cevik C, Ozveren O, Sunbul A, Kilicarslan F, Oduncu V, Can M, Semiz  E, Dindar I. Assessment of atrial conduction time in patients with coronary artery ectasia. Pacing Clin Electrophysiol. 2011 Nov;34(11):1468-74. doi: 10.1111/j.1540-8159.2011.03165.x.
  • A15. Sengul C, Ozveren O, Duman D, Eroglu E, Oduncu V, Tanboga HI, Can MM, Akgun T, Dindar I. Echocardiographic epicardial fat thickness is related to altered blood pressure responses to exercise stress testing. Blood Press. 2011 Oct;20(5):303-8. doi: 10.3109/08037051.2011.569992.
  • A16. Can MM, Tanboğa IH, Türkyilmaz E, Karabay CY, Akgun T, Koca F, Tokgoz HC, Keles N, Ozkan A, Bezgin T, Ozveren O, Sonmez K, Sağlam M, Ozdemir N, Kaymaz C. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays. Thromb Res. 2010 ;125(4):e132-7. doi: 10.1016/j.thromres.2009.11.005. 
  • A17. Bitigen A, Cevik C, Biteker M, Can M, Ozdemir N. Takotsubo cardiomyopathy in a 52 year old patient. Int J Cardiol. 2009;132(1):e23-5.
  • A18. Can MM, Kaymaz C, Can E, Tanboğa IH, Api O, Kars B, Ceren Tokgoz H, Turkyilmaz E, Akgun T, Sonmez K, Saglam M, Turan C, Unal O, Serebruany V. Whole blood platelet aggregation failed to detect differences between preeclampsia and normal pregnancy. Platelets. 2010;21(6):496-7. doi: 10.3109/09537101003797275.
  • A19. Can MM, Tanboğa IH, Demircan HC, Ozkan A, Koca F, Keleş N, Sönmez K, Kaymaz C, Serebruany V. Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study. Thromb Res. 2010;126(4):280-2. doi: 10.1016/j.thromres.2010.06.020.
  • A20. Sengul C, Cevik C, Ozveren O, Oduncu V, Sunbul A, Akgun T, Can MM, Semiz E, Dindar I. Echocardiographic epicardial fat thickness is associated with carotid intima-media thickness in patients with metabolic syndrome. Echocardiography. 2011;28(8):853-8. doi: 10.1111/j.1540-8175.2011.01471.x.
  • A21. Can MM, Can E, Turan B, Kaymaz C. Atipic electrocardiographic manifestation of pulmonary embolism. Resuscitation. 2010;81(12):1738-9. doi: 10.1016/j.resuscitation.2010.07.023.
  • A22. Karabay CY, Can MM, Tanboga IH, Aung SM, Kalayci A, Gecmen C, Kirma C. Spontaneous coronary artery dissection associated with Leriche syndrome. Cardiovasc J Afr. 2012;23(3):e3-5. doi: 10.5830/CVJA-2011-012.
  • A23. Can E, Can MM, Tanboga IH, Api O, Biteker M,Unal O.High- Density Lipoprotein Cholosterol May Discriminate Mild and Severe Preeclampsia
  • A24 Can MM, Can E, Ozveren O, Okuyan E, Ayca B, Dinckal MH. Epicardial fat tissue thickness in preeclamptic and normal pregnancies. ISRN Obstet Gynecol. 2012;2012:389539. doi: 10.5402/2012/389539.
  • A25. Enhos A, Sahin I, Can MM, Biter I, Dinckal MH, Serebruany V. Relation of coronary collateral circulation with epicardial fat volume in patients with stable coronary artery disease. J Geriatr Cardiol. 2013;10(4):344-8. doi: 10.3969/j.issn.1671-5411.2013.04.006.
  • A26. Kurt M, Tanboga IH, Isik T, Kaya A, Ekinci M, Bilen E, Can MM, Karakas MF, Bayram E, Aksakal E, Sevimli S. Comparison of transthoracic and transesophageal 2-dimensional speckle tracking echocardiography. J Cardiothorac Vasc Anesth. 2012;26(1):26-31. doi:10.1053/j.jvca.2011.05.014.
  • A27. Can MM, Biteker M, Babur G, Ozveren O, Serebruany VL. Knowledge, attitude and perception of antiplatelet therapy among dentists in Central Eastern Turkey.World J Cardiol. 2012 ;4(7):226-30. doi: 10.4330/wjc.v4.i7.226
  • A28. Toptas M, Akkoc İ, Savas Y, Uzman S, Toptas Y, Can MM. Novel hematologic inflammatory parameters to predict acute mesenteric ischemia. Blood CoagulFibrinolysis. 2016;27(2):127-30. doi: 10.1097/MBC.0000000000000372.
  • A29. Can MM, Tanboga IH, Akgun T. Diffuse involvement of aorta in patient with familial hyperlipidemia. ISRN Cardiol. 2011;2011:804767. doi:10.5402/2011/804767.
  • A30. Can MM, Guler G, Guler E, Ozveren O, Turan B, DiNicolantinio JJ, Kipshidze N,  Serebruany V. Enhanced platelet reactivity in pediatric depression: an observational study. Blood Coagul Fibrinolysis. 2015;26(7):731-5. doi: 10.1097/MBC.0000000000000245.
  • A31. Gunes HM, Guler GB, Guler E, Demir GG, Hatipoglu S, Zehir R, Kizilirmak F, Karaca O, Esen AM, Barutcu I, Turkmen MM, Can MM, Serebruany VL. Impact of valve  surgery on serum osteopontin levels in patients with mitral regurgitation. Cardiology. 2015;130(2):82-6. doi: 10.1159/000368299.
  • A32. Sahin I, Gungor B, Can MM, Avci II, Guler GB, Okuyan E, Biter H, Yildiz SS, Ayca B, Satilmis S, Dinckal MH. Lower blood vitamin D levels are associated with  an increased incidence of contrast-induced nephropathy in patients undergoing coronary angiography. Can J Cardiol. 2014 Apr;30(4):428-33. doi: 10.1016/j.cjca.2013.12.029.
  • A33. Serebruany VL, Fortmann SD, Rao SV, Tanguay JF, Lordkipanidzé M, Hanley DF, Can M, Kim MH, Marciniak TA. Vorapaxar and diplopia: Possible off-target PAR-receptor mismodulation. Thromb Haemost. 2016;115(5).
  • A34. DiNicolantonio JJ, Can MM, Serebruany VL. Lost in follow-up rates in TRACER, ATLAS ACS 2, TRITON and TRA 2P trials: challenging PLATO mortality rates. Int J Cardiol. 2013;164(3):255-8. doi: 10.1016/j.ijcard.2012.09.113.
  • A35. Serebruany VL, DiNicolantonio JJ, Can MM. Mortality in the TRACER and ATLAS ACS 2 trials: two more reasons to audit vital records in PLATO. Cardiology. 2012;123(1):11-4. doi: 10.1159/000342085.
  • A36. Biteker M, Tekkeşin Aİ, Can MM, Dayan A, Ilhan E, Türkmen FM. Outcome of
  • noncardiac and nonvascular surgery in patients with mechanical heart valves. Am J Cardiol. 2012;110(4):562-7. doi: 10.1016/j.amjcard.2012.04.031. 
  • A37. Can MM, Kaymaz C, Pochi N, Aktimur T. Impact of pulmonary arterial hypertension and its therapy on indices of heart rate variability. Med Glas(Zenica). 2013;10(2):249-53.
  • A38. Karabay CY, Can MM, Tanboğa IH, Ahmet G, Bitigen A, Serebruany V. Recurrent acute stent thrombosis due to allergic reaction secondary to clopidogrel therapy. Am J Ther. 2011;18(4):e119-22. doi: 10.1097/MJT.0b013e3181cdb98c. 
  • A39. Ayça B, Akın F, Şahin I, Yıldız SS, Can MM, Avcı II, Çelik Ö, Okuyan E, Dinçkal MH. The effect of atorvastatin on P wave dispersion in hyperlipidemic patients. Med Glas (Zenica). 2013;10(2):234-8.
  • A40. Serebruany VL, Dinicolantonio JJ, Can MM, Pershukov IV, Kuliczkowski W. Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive. Cardiology. 2013;126(1):35-40. doi: 10.1159/000350961.
  • A41. Serebruany VL, DiNicolantonio JJ, Can MM, Dukhanin A, Tomek A. Mortality after clopidogrel in the non-invasive PLATO cohort and TRILOGY ACS trial: another mismatched death paradox. Int J Cardiol. 2013;168(2):640-2. doi:10.1016/j.ijcard.2013.05.066.
  • A42. Tanboğa IH, Karabay CY, Can MM, Akgün T, Güler A, Turkylmaz E, Ozveren O, Kaymaz C. Kounis syndrome presenting with cardiogenic shock. J Cardiovasc Med (Hagerstown). 2011;12(11):833-6. doi: 10.2459/JCM.0b013e32833b97a9. 
  • A43. Can M, Tanboga IH, Akgun T, Turkyilmaz E, Aung SM, Yilmaz F, Kaya Z, Boztosun  B, Kaymaz C. Type A intramural hematoma presenting with acute right heart failurecaused by compression of the main pulmonary artery: a case report. Ann Vasc Surg. 2009;23(4):535.e11-4. doi: 10.1016/j.avsg.2008.08.024.
  • A44. Sahin I, Karabulut A, Avci II, Okuyan E, Biter HI, Yildiz SS, Can MM, GungorB, Dinckal M, Serebruany V. Contribution of platelets indices in the development of contrast-induced nephropathy. Blood Coagul Fibrinolysis. 2015;26(3):246-9. doi: 10.1097/MBC.0000000000000107.
  • A45. Serebruany VL, Dinicolantonio JJ, Can MM, Goto S. Unclassified pleomorphic and spindle cell pulmonary neoplasm with brain metastases after prasugrel. Cardiology. 2013;124(2):85-90. doi: 10.1159/000346382. 
  • A46. Toptas M, Asik H, Kalyoncuolglu M, Can E, CanM.  Are Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio Predictors of Severity of Preeclampsia? J Clin Gynecol Obstet.2016;5 (1):27-31
  • A47. Guler GB, Can MM, Guler E, Akinci T, Sogukpinar O, Hatipoglu S, Kilicaslan F,  Serebruany VL. Asymptomatic Pulmonary Embolism after Ablation. Cardiology. 2016;134(4):426-32.
  • A48. Kalyoncuoglu M, Biter Hİ, Ozturk S, Belen E, Can MM. Predictive accuracy of lymphocyte-to-monocyte ratio and monocyte-to-high-density-lipoprotein-cholesterol ratio in determining the slow flow/no-reflow phenomenon in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020  doi: 10.1097/MCA.0000000000000848.
  • A49. Ozturk S, Durmus G, Kalyoncuoglu M, Sari M, Ozbek O, Can M. Unroofed Coronary  Sinus Atrial Septal Defect Misdiagnosed as Ostium Primum Defect. Korean Circ J. 2018 ;48(1):89-90. doi: 10.4070/kcj.2017.0131
  • A50. Sahin M, Öztürk S, Mert TI, Durmuş G, Can MM. Coronary artery bypass surgery in Syrian refugees. Outcomes in a Turkish tertiary center. Saudi Med J. 2018;39(8):781-786. doi: 10.15537/smj.2018.8.22498.
  • A51. Durmuş G, Belen E, Can MM. Increased neutrophil to lymphocyte ratio predicts myocardial injury in patients undergoing non-cardiac surgery. Heart Lung. 2018. doi: 10.1016/j.hrtlng.2018.01.005.
  • A52. Durmuş G, Belen E, Bayyigit A, Kalyoncuoğlu M, Can MM. The Relationship
  • between Inter-Arm Blood Pressure Difference and Coronary Artery Disease Severity  Calculated by the SYNTAX Score. Int J Hypertens. 2018 ;2018:9370417. doi: 10.1155/2018/9370417. 
  • A53. Durmuş G, Belen E, Bayyiğit A, Can MM. Comparison of Complication and Success Rates of ProGlide Closure Device in Patients Undergoing TAVI and Endovascular Aneurysm Repair. Biomed Res Int. 2018:2687862. doi: 10.1155/2018/2687862. 
  • A54.  Toptas M, Yalcin M, Akkoc İ, Demir E, Metin C, Savas Y, Kalyoncuoglu M, CanMM. The Relation between Sarcopenia and Mortality in Patients at Intensive Care Unit. Biomed Res Int. 2018 ;2018:5263208. doi: 10.1155/2018/5263208.
  • A55. Toptas M, Sengul Samanci N, Akkoc İ, Yucetas E, Cebeci E, Sen O, Can MM,Ozturk S. Factors Affecting the Length of Stay in the Intensive Care Unit: Our Clinical Experience. Biomed Res Int. 2018;2018:9438046. doi: 10.1155/2018/9438046. 
  • A56. Kalyoncuoglu M, Biter Hİ, Ozturk S, Belen E, Can MM. Predictive accuracy of lymphocyte-to-monocyte ratio and monocyte-to-high-density-lipoprotein-cholesterol ratio in determining the slow flow/no-reflow phenomenon in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020 . doi:10.1097/MCA.0000000000000848.
  • A57. Toptas M, Akkoc İ, Savas Y, Uzman S, Toptas Y, Can MM. Novel hematologic inflammatory parameters to predict acute mesenteric ischemia. Blood Coagul Fibrinolysis. 2016 ;27(2):127-30. doi: 10.1097/MBC.0000000000000372.
  • A58.Role of dyslipidemia in early vascular aging syndrome Alparslan KILIÇ 1, Onur BAYDAR, Deniz ELÇİK, Ziya APAYDIN, Mehmet Mustafa CAN Turk J Med Sci. 2021; 51(2): 727–734.  doi: 10.3906/sag-2008-165
  • A59. Prognostic Value of Systemic Immune-Inflammation Index for Major Adverse Cardiac Events and Mortality in Severe Aortic Stenosis Patients after TAVI Aydin Rodi Tosu, Muhsin Kalyoncuoglu, Halil İbrahim Biter, Sinem Cakal, Murat Selcuk, Tufan Çinar, Erdal Belen, Mehmet Mustafa Can Medicina (Kaunas) 2021 Jun; 57(6): 588.  doi: 10.3390/medicina57060588
  • A60.Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina Sinem Cakal, Beytullah Cakal, Zafer Güven, Aydın Rodi Tosu, Muhsin Kalyoncuoglu, Halil Ibrahim Biter, Ziya Apaydın, Ibrahim Oguz Karaca, Erdal Belen, Mehmet Mustafa Can J Clin Med. 2021 Jun; 10(11): 2463.  doi: 10.3390/jcm10112463
  • A61. Predicting One-Year Deaths and Major Adverse Vascular Events with the Controlling Nutritional Status Score in Elderly Patients with Non–ST-Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention Muhsin Kalyoncuoğlu, Fahrettin Katkat, Halil Ibrahim Biter, Sinem Cakal, Aydin Rodi Tosu, Mehmet Mustafa Can J Clin Med. 2021 Jun; 10(11): 2247.  doi: 10.3390/jcm10112247
  • A62. The effect of recanalization of a chronic total coronary occlusion on P-wave dispersion Aydın Rodi Tosu, Muhsin Kalyoncuoğlu, Halil İbrahim Biter, Sinem Çakal, Beytullah Çakal, Tufan Çınar, Erdal Belen, Mehmet Mustafa Can J Cardiovasc Thorac Res. 2021; 13(3): 222–227.  . doi: 10.34172/jcvtr.2021.38
  • A63. Prognostic value of the C-reactive protein to albumin ratio in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction Özgür SÖĞÜT, Tarık AKDEMİR, Mehmet Mustafa CAN Turk J Med Sci. 2021; 51(3): 1281–1288.  . doi: 10.3906/sag-2003-188
  • A64.  Kalyoncuoglu M, Biter Hİ, Ozturk S, Belen E, Can MM. Predictive accuracy of lymphocyte-to-monocyte ratio and monocyte-to-high-density-lipoprotein-cholesterol ratio in determining the slow flow/no-reflow phenomenon in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020 Sep;31(6):518-526. doi: 10.1097/MCA.0000000000000848. PMID: 32040024.
Papers presented at international scientific meetings and published in the proceedings book:
  • B1.Kaymaz C, Keleş N, Tanboga IH, Can MM, Tokgöz H.C, Koca F, Ozkan A, Sonmez K, Saglam M, Ozdemır N.The effects of pre, peri or postprocedural infusion of tirofiban on angiographic measures, ST segment resolution, and in-hospital clinical outcome after primay PCI Eur Heart J (2011) 32 (suppl 1): 313-631 DOI: http://dx.doi.org/10.1093/eurheartj/ehr323
  • B2. Biteker M, Biteker F, Ilhan E, Dayan A, Can M.M., Duman D. C-Reactive Protein (CRP) can predict perioperative major cardiovascular events in patients undergoing noncardiac, nonvascular surgery PCI Eur Heart J (2011) 32 (suppl 1): 313-631 DOI: http://dx.doi.org/10.1093/eurheartj/ehr323B3.
  • B3.Biteker M, Dayan A, Tekkeşin A, Can M.M., Ilhan E.Incidence, risk factors, and outcomes of perioperative Acute Kidney Injury in noncardiac and nonvascular surgery Eur Heart J (2012) 33 (suppl 1): 655-939 DOI: http://dx.doi.org/10.1093/eurheartj/ehs283
  • B4. Can MM, Tanboga I.H, Tokgoz H.C., Saglam M, Ozdemir N, Kaymaz C. The prognostic value of PET/CT uptake of bone marrow in patients with idiopathic pulmonary arterial hypertension PCI Eur Heart J (2011) 32 (suppl 1): 313-631 DOI: http://dx.doi.org/10.1093/eurheartj/ehr323
  • B5. Biteker M, Dayan A,Can M.M., Ilhan E, Tekkesin T Preoperative statin use and postoperative atrial fibrillation after major noncardiac, nonvascular surgery Eur Heart J (2012) 33 (suppl 1): 655-939 DOI: http://dx.doi.org/10.1093/eurheartj/ehs283 
  • B6. Biteker M, Ilhan E ,Can M.M., Tekkesin T, Dayan A . The predictive value of preoperative B-type natriuretic peptide for major adverse cardiac/noncardiac events in patients undergoing noncardiac, nonvascular surgery Eur Heart J (2012) 33 (suppl 1): 19-338 DOI: http://dx.doi.org/10.1093/eurheartj/ehs281
  • B7.Biteker M, Misirli C.H., Dayan A, Tekkeşin A, Ozden T,Can M.M, Ilhan E. Left atrial volume indexis an independent predictor of mortality after a firts -ever acute ischemic stroke Eur Heart J (2012) 33 (suppl 1): 19-338 DOI: http://dx.doi.org/10.1093/eurheartj/ehs281
  • B8. Biteker M, Can M.M, Biteker F, Ilhan E, Dayan A, Duman D. An unforgotten predictor of perioperative outcome in patients undergoing noncardiac surgery:pulmonary hypertension Eur Heart J (2011) 32 (suppl 1): 1-312 DOI: http://dx.doi.org/10.1093/eurheartj/ehr322 
  • B9.Biteker M, Dayan A, Can M.M, Ilhan E, Duman D. Impact of perioperative glucose levels  on perioperative cardiovascular outcomes in patients unergoing intermediate-risk mojor noncardiacsurgeryEurHeartJ (2011) 32 (suppl1): 1312 DOI: http://dx.doi.org/10.1093/eurheartj/ehr322 
  • B10. I.H Tanboga, Tokgoz H.C., Can M.M, Bezgin T, Turkyilmaz E, Akgun T, Sonmez K, Saglam M, Ozdemir N, Kaymaz C. The polymorphisms of CYP2C19, CYP3A5 and CYP2C9 enzymes in relation to platelet response to clopidogrel as assessed by multiplate analyser and long-term clinical outcome Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B11. Tokgoz H.C., I.H Tanboga, , Can M.M, Bezgin T, Akgun T, Turkyilmaz E, Sonmez K, Saglam M, Ozdemir N, Kaymaz C. Does platelet response to clopidogrel and/or aspirin as assessed by multiplate analyser predict short and long term outcome following coronary stenting Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B12. Tokgoz H.C., I.H Tanboga, , Ozkan A, Can M.M, Koca F,  Bezgin T, Keles N, Ozveren O, Ozdemir N, Kaymaz C. A novel Doppler parameter, apical systolic flow in prediction of mitral regurgitation severity: Reappraisal of regurgitaion dynamics Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B13. Tokgoz H.C., Ozkan A, I.H Tanboga, , Koca F,   Can M.M, Keles N, Bezgin T, Sonmez K, Ozdemir N, Kaymaz C. Color M- mode regurgitant flow propagation velocity in quantitaion of mitral regurgitation:A high negative predictive value of jet eccentricity and dp/dt Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B14. Can MM, Tanboga I.H, Tokgoz H.C., Keles N, Koca F, Ozkan A, Turkyilmaz E, Ozveren O, Sonmez K,Saglam M, Kaymaz C. Does heart rate variability predict te prognose in patinets with pulmonary arterial hypertension  Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B15. Can MM, Tanboga I.H, Turkyilmaz E, Akgun T,  Koca F, Tokgoz H.C., Ozkan A, Bezgin T,  Ozveren O, Kaymaz C. Characterization of platelet activity in paitients with pulmonary arterial hypertension.  ESC 2013
  • B16. Koca F, Can MM, Tanboga I.H, Ozkan A, Tokgoz H.C., Keles N, Bezgin T , Akgun T,  Turkyilmaz  E,  Kaymaz C. Is neutrophil gelatinase-associated lipocalin a marker of renotubular dysfunction in pulmonary arterial hypertension characterised by low arteriovenous perfusion gradients  Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B17. Can MM, Tanboga I.H, Ozkan A, Koca F, Keles N, Tokgoz H.C, Yaymaci B, Sonmez K, Saglam M,  Kaymaz C. In vitro assesment of platelet activity in patients with pulmonary arterial hypertension Eur Heart J (2012) 30 (suppl 1): 1-300 
  • B18. Can MM, Tanboga I.H, Turkyilmaz  E, Akgun T,  Koca F, Tokgoz H.C.,   Ozkan A, Bezgin T , Ozveren O, Kaymaz C.  Increased platelet reactivity and thrombogenesis in pulmonary arterial hypertension subgroups  Eur Heart J (2009) 30 (suppl 1): 587-843 DOI: http://dx.doi.org/10.1093/eurheartj/ehp415
  • B19. Tanboga I.H, Can MM, Tokgoz H.C, Akgun T, Turkyilmaz  E, , Keles N, Ozkan A, Ozveren O, Kaymaz C. Role of brain natriuretic peptide levels in predicting the acute clinical worsening episodes and response to ilioprost infusion in patients with pulmonary arterial hypertension.EurHeartJ (2009) 30 (suppl1): 587843 DOI: http://dx.doi.org/10.1093/eurheartj/ehp415
  • B20. Can MM, Tanboga I.H, Tokgoz H.C., , Koca F, Ozkan A, Turkyilmaz E, Ozveren O, Sonmez K, Kaymaz C. The effects of long-term specific therapy on clinical outcome, echocardiographic ans sympatho-vagal balance as assessed by heart rate variability in pulmonaryarterialhypertension.EurHeartJ (2009) 30 (suppl1): 587843 DOI: http://dx.doi.org/10.1093/eurheartj/ehp415
  • B21. Can MM, Tanboga I.H, Tokgoz H.C., Turkyilmaz  E, Akgun T, Koca F, Ozkan A,  Saglam M, Ozveren O, Kaymaz C.   Does sympathovagal imbalance predict clinical outcome in patienys with PAH? Eur Heart J (2009) 30 (suppl 1): 1-300 DOI: http://dx.doi.org/10.1093/eurheartj/ehp413.
  • B22. Karabay C, Can MM, Tanboga I.H, Akgun T, Turkyilmaz  E, Ozkan A,  Koca F, Keles N, Bezgin T, Saglam M, Yaymaci B, Sonmez K, Ozdemir N, Kaymaz C.   Verify-Now Assay had discordant results as compared to Impedance Aggregometry in the evaluation of antiplatelet treatment in patients with stenting. 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9
  • B23. Tanboga I.H, Tokgoz H.C, Can MM, Turkyilmaz  E, Akgun T , Karabay C.Y, Bezgin T, Keles N,  Koca F, Ozkan A, Sonmez K, Sağlam M, Yaymaci B, Ozdemir N, Kaymaz C. Does serum Lipoprotein (a) corelates to different riskfactors, coronary artery disease and angiographic data? 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9
  • B24. Turkyimaz E, Tanboga I.H, Tokgoz H.C, Can MM, Akgun T, Bezgin T, Karabay C.Y,  Keles N, Ozkan A, Koca F, Saglam M, Yaymaci B, Sonmez K, Ozdemir N, Kaymaz C.     Serum Lipoprotein  (a) and homocysteine levels related to five risk scores for coronary artery disease. 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9
  • B25. Koca F, Keles N, Tokgoz H.C, Ozkan A, Tanboga I.H, Karabay C.Y, Can MM,  Bezgin T, Akgun T,  Turkyimaz E,  Saglam M, Yaymaci B, Sonmez K, Bitigen A, Mutlu  B, Duran N, Ozdemir N, Kaymaz C. Does clopidogrel provide an additıve early benefit in patients under the tirofiban treatment? 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9
  • B26. Can MM, Tanboga I.H, Akgun T, Turkyimaz E , Tokgoz H.C, Keles N,  Koca F, Ozkan A, Karabay C.Y, Bezgin T, Dogan C, Omaygenc O,   Yaymaci B, Sonmez K, Saglam M,  Ozdemir N, Kaymaz C. Does types of bare metal or drug eluting stents, clinical and biochemical markers of atherothrombosis attenuate the effect of antiplatelets. 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9
  • B27. Can MM, Tanboga I.H, Tokgoz H.C., Karabay C.Y, Akgun T, Turkyilmaz E, Keles N, Ozkan A, Koca F, Bezgin T, Yaymaci B, Kaymaz C. The characteristics of acute clinical worsening in pulmonary hypertension, and substantial benefit from ilioprost infusion added on specific treatment. European Journal of Clinical Investigation 2008;38
  • B28. Keles N, Tokgoz H.C., Koca F, Tanboga I.H, Karabay C.Y, Can MM, Bezgin T, Turkyilmaz E, Akgun T, Sonmez K, Yaymaci B, Bitigen A, Duran N.E,Mutlu B, Ozdemir N, Kaymaz C.    Effects of tirofiban on angiographic measures, st resolution, and clinical outcome following the primary coronary intervention in patients with STEMI. 77th Congress of the European Atherosclerosis Society, İSTANBUL, TÜRKIYE, 26-29 Temmuz 2008, vol.9
  • B29. Can MM, Tanboga I.H, Turkyilmaz E, Akgun T, Tokgoz H.C., Karabay C.Y, Bezgin T,  Keles N, Ozkan A, Koca F, Yaymaci B, Kaymaz C. Does platelet activity have to be maesured before the treatment toı reflect the antiplatelets effect properly European Journal of Clinical Investigation 2008;38
  • B30.Can MM, , Tokgoz H.C., , Turkyilmaz E, Tanboga IH, Akgun T, Ozkan A, Keles N, Koca F,   Sonmez K,  Kaymaz C. The characteristics of acute clinical worsening in pulmonary hypertension, and substantial benefit from ilioprost infusion added on specific treatment. Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B31. Can MM, Canpolat N, Tanboga IH, Saglam M, Yaymaci B, Kaymaz C.  Does enhanced F18 flurodeoxyglucose accumulation in right ventricular myocardium predict the severity of the disease and correlate with contractile function of the right ventricule? . European Journal of Clinical Investigation 2008;38
  • B32. Tanboga IH, Karabay C.Y, Turkyilmaz E, Can MM, Akgun T, Bezgin T, Tokgoz H.C.,    Ozkan A, Koca F, Keles N, Sonmez K, Kaymaz C. Serum lipoprotein(A) in association with patient characteristics, clinical risk groups, presentation of coronary artery disease and angiographic data. European Journal of Clinical Investigation 2008;38
  • B33. Can MM, Tokgoz H.C., Tanboga IH, Turkyilmaz E, Akgun T, Ozkan A, Deniz S, , Koca F, Sonmez K, Kaymaz C.    Problems in quantitaion of dual antiplatelet efficiacy;discordant results on verify-now assay compared with impedance aggregometry in patients with coronary stent Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B34. Can MM, Tanboga I.H, Tokgoz H.C., Karabay C.Y, Turkyilmaz E, Akgun T, Koca F,    Keles N, Ozkan A, Bezgin T, Yaymaci B, Kaymaz C. Does heart rate variability predict te prognose in patients with pulmonary arterial hypertension  European Journal of Clinical Investigation 2008;38.
  • B35. Bezgin T, Tanboga I.H, Can MM, Akgun T, Turkyilmaz E, Keles N, Koca F, Ozkan A, Sonmez K, Kaymaz C. Genetic determinanats in venous thrombosis. Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B36. Can MM, Tanboga I.H, Turkyilmaz E, Akgun T,  Elveran A, Keles N, Karabay C.Y, Saglam M, Sonmez K, Kaymaz C. Does platelet activity have to be maesured before the treatment toı reflect the antiplatelets effect properly Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B37. Tanboga I.H, , Tokgoz H.C, Akgun T, Turkyilmaz E, Can MM, Karabay C.Y, Bezgin T, Koca F, Keles N, Ozkan A, Sonmez K,  Kaymaz C.  Serum homocysteine and lipoprotei (a) levels in relation to five risk scores for coronary artery disease. European Journal of Clinical Investigation 2008;38
  • B38. Tanboga I.H, Can MM, Turkyilmaz E, Akgun T, Karabay C.Y, Tokgoz H.C. , Bezgin T, Keles N, Koca F, Ozkan A, Sonmez K, Kaymaz C.    Serum homocysteine in relation to patient characteristics, clinical risk groups, presentaion of coronary artery disease and angiographic involvement. European Journal of Clinical Investigation 2008;38
  • B39. Tanboga I.H, Can MM, Turkyimaz E, Akgun T , Tokgoz H.C, Koca F, Keles N,  Ozkan A, Sonmez K, Kaymaz C.  Quantitaion of volumetric coronary perfusion and prediction of in-hospital mortality from timi framecount in patients who underwent primary coronary intervention. Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B40. Tanboga I.H, Turkyimaz E , Akgun T, Can MM, Koca F, Keles N, Tokgoz H.C,  Ozkan A, Saglam M,  Kaymaz C  Tirofiban improves coronary reperfusion as assesed by corrected TIMI frame count and volumetric TIMI perfusion, and increases survival benefiy from primary coronary intervention in STEMI. Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B 41. Tanboga I.H, Turkyimaz E , Akgun T, Ozkan A, Tokgoz H.C, Can MM,  Keles N, Bezgin T, Koca F,  Kaymaz C  Comparison of the five different risk scoring models, lipoprotein (a) and homocysteine levels with respect to clinical presentation and angiographic severity of coronary artery disease. Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B42.Biteker M, Duman D, Dayan A, Can M.M., Ilhan E. Increased aortic stiffness can predict perioperative cardiovascular outcomes in patients undergoing intermediate-risk major noncardiac surgery. Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B43. Biteker M, Ilhan E, Duman D, Can M.M., Dayan A. Delayed recovery in peripartum cardiomyopathy: an indication for long term follow-up and sustained therapy. Eur Heart J (2013) 30 (suppl 1): 1-300 
  • B44. Kaymaz C, Tanboga I.H, Tokgoz H.C, Poci N, Can M.M., , Kirca N, Aktimur T, Saglam M, Ozdemir N.  Clinical, procedural, cardiometabolic and laboratory correlates of platelet reactivity to clopidogrel and aspirin on multiplate analyserin patients with coonary stenting. Eur Heart J (2011) 32 (suppl 1): 633-933 DOI: http://dx.doi.org/10.1093/eurheartj/ehr324
  • B45. Kaymaz C, Tanboga I.H, Tokgoz H.C, Poci N, Kirca N, Aktimur T, Can M.M.,  Saglam M, Ozdemir N.  The time-dependent loss in platelet response in platelet response to aspirin and clopidogrel: implications for patient compliance to antiplatelets Eur Heart J (2011) 32 (suppl 1): 633-933 DOI: http://dx.doi.org/10.1093/eurheartj/ehr324
  • B46. Kaymaz C, Tanboga I.H, Tokgoz H.C, Poci N, Kirca N, Aktimur T, Can M.M.,  Saglam M, Ozdemir N.  Can we translate the high and low on treatment platelet reactivity to early, mid and longterm risks for ischemic and bleeding events following the stent placement Eur Heart J (2011) 32 (suppl 1): 633-933 DOI: http://dx.doi.org/10.1093/eurheartj/ehr324
  • B47. Kaymaz C, Tanboga I.H, Tokgoz H.C, Can M.M.,  Poci N, Aktimur T,  Kirca N, Saglam M, Ozdemir N.  Comparison of multiplate, verify-now and PFA-100 in the assesment of on treatment platelet reactivity in patients treated with aspirin and clopidogrel following coronary 
  • B48. Kaymaz C, Tanboga I.H, Can M.M.,  Tokgoz H.C, Sonmez K, Saglam M, Ozdemir N. Gene mutations or polymorphisms in association with platelet response to aspirin and or clopidogrel and long-term clinical outcome following coronary stenting. Eur Heart J (2011) 32 (suppl 1): 1-312 DOI: http://dx.doi.org/10.1093/eurheartj/ehr322 

 

 

International books or chapters in books:
  • C1.Pulmoner Hipertansiyon Mayıs 2012 . Endotelin Reseptör Antagonistleri AVES Yayıncılık
  • C2. Pulmoner Hipertansiyon Mayıs 2012 . Kanıta Dayalı Tıp Işığında Pulmoner Hipertansiyonda Sonlanım Noktaları   AVES Yayıncılık
  • C3. SEMPTOMLAR VE KLINIK DURUMLAR 2019, Göğüs Ağrısı  NOBEL TIP KİTABEVİ

 

  • Turkish Society of Cardiology
  • European Society of Cardiology
  • Turkish Society of Cardiology-Eczacıbaşı Zentiva Best Interventional Case Award Winner 2008
  • Siemens Echocardiography Keypad Competition with Prizes
  • Turkish Society of Cardiology-Actelion Best Research First Prize 2011
  • Turkish Society of Cardiology "Most Successful Article of the Year" Award 2011
  • Transcatheter aortic valve implantation certification
  • Stroke (Acute stroke) certificate
  • Atrial fibrillation ablation certificate
  • Experience in endovascular aortic interventions (EVAR)
Ask our Experts!
You can contact with our experts for your questions!